logo

For the Inventor, By the Inventor

Ingelheim am Rhein, Germany

Boehringer Ingelheim Vetmedica Gmbh


USPTO Granted Patents = 306



Trademarks = 204

Forward Citations = 1,620

Loading Chart...
Loading Chart...

553 inventors (with patents filed for the assignee):

goldMedal Michael B Roof (29 out of 38 patents)

silverMedal Knut Elbers (28 out of 31 patents)

bronzeMedal Marc Allan Eichmeyer (24 out of 29 patents)

4.  Martin Andreas Folger (21 out of 22 patents)

5.  Eric Martin Vaughn (20 out of 43 patents)

6.  Guido Endert (19 out of 24 patents)

7.  Phillip Wayne Hayes (19 out of 21 patents)

8.  Merrill Lynn Schaeffer (18 out of 23 patents)

9.  Horst Wergen (17 out of 21 patents)

10.  Walter Gumbrecht (17 out of 62 patents)

11.  Vicky Fachinger (15 out of 21 patents)

12.  Peter Paulicka (15 out of 37 patents)

13.  Marion Kixmoeller (14 out of 15 patents)

14.  Marcus Rainer Rahmel (13 out of 13 patents)

15.  Jeremy Kroll (13 out of 19 patents)


Core Competencies:
Avian Vaccine Production
SGLT-2 Inhibitors
Inhaler Technology
Immunogenic Composition
Coronovirus Spike Protein
Anthelmintic Compounds
Peristaltic Pump
Biological Sample Testing
Fluid Sensor Technology
Veterinary Blood Pressure Measurement
Pharmaceutical Formulation
DNA Analysis Systems

306 patents:

1. 12441989 - Serum-free medium for avian vaccine production and uses thereof (2025-10-14),
2. 12435083 - Cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivatives (2025-10-07),
3. 12403191 - Attenuated IBV with extended cell culture and tissue tropism (2025-09-02),
4. 12397009 - Use of SGLT-2 inhibitors in the drying-off of non-human mammals (2025-08-26),
5. 12350424 - Inhaler (2025-07-08),
6. 12329719 - Administration packaging and method for its production (2025-06-17),
7. 12221267 - Container system (2025-02-11),
8. 12128178 - Inhalers as well as protective device and breath indicator (2024-10-29),
9. 12098166 - Immunogenic composition against avian influenza virus H5 subtype (2024-09-24),
10. 11999766 - Modified S1 subunit of the coronavirus spike protein (2024-06-04),
11. 11992461 - Connecting and container system (2024-05-28),
12. 11964102 - Inhaler (2024-04-23),
13. 11730805 - Paramyxoviridae expression system (2023-08-22),
14. 11696947 - H52 IBV vaccine with heterologous spike protein (2023-07-11),
15. 11679212 - Inhaler (2023-06-20),
Boehringer Ingelheim Vetmedica GmbH is a leading company in the animal health industry. With a focus on research, development, and production of innovative veterinary medicines and vaccines, they provide solutions for the prevention and treatment of various animal diseases. Boehringer Ingelheim Vetmedica GmbH strives to improve animal health and well-being, thereby contributing to healthier and more productive animals. For more information about their products and services, please visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
306 Patents

#2 in Ingelheim am Rhein

#210 in Germany

#2,831 in the World

...
Ingelheim am Rhein, Germany

Boehringer Ingelheim Vetmedica Gmbh

Forward Citations = 1,620

553 inventors:

goldMedal Michael B Roof (29 out of 38 patents)

silverMedal Knut Elbers (28 out of 31 patents)

bronzeMedal Marc Allan Eichmeyer (24 out of 29 patents)

4.  Martin Andreas Folger (21 out of 22 patents)

5.  Eric Martin Vaughn (20 out of 43 patents)

Please report any incorrect information to support@idiyas.com
Loading…